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Objective: Dibutyryl adenosine 3',5'cyclic monophosphate (db-cAMP) is a 
membrane-permeable analog of adenosine 3',5'cyclic monophosphate 
(cAMP). We examined the effect of db-cAMP against lung injury caused by 
cold preservation and ischemia-reperfusion. Methods: Rats were divided 
into three groups (each n = 6) according to the presence or absence of 
db-cAMP in the preservative solution and cold ischemia (4 ° C for 15 hours). 
In the fresh group, the lung was flushed with the preservative solution and 
reperfusion was performed immediately. In the control group and the 
db-cAMP group, the lung was flushed either with the solution or with a 
combination of the solution plus db-cAMP, respectively, and preserved at 
4 ° C for 15 hours. The lung was reperfused for 60 minutes in an ex vivo rat 
lung perfusion model. Results: The shunt ratios of the reperfused lung in the 
db-cAMP group were 4.0% +_ 1.6% and 3.4% +__ 1.2% 10 and 60 minutes, 
respectively, after the initiation of reperfusion, being as low as those in the 
fresh group and significantly lower than those in the control group (p < 
0.01). The wet/dry weight ratio of the lung tissue after reperfusion was 
5.99 - 1.50 in the db-cAMP group, which was similar to that in the fresh 
group (5.45 +_ 0.23) and significantly lower than that in the control group 
(14.20 -+ 3.43) (p < 0.01). Electron microscopic examination showed less 
damage in the pulmonary arterial endothelium in the db.cAMP group. 
Conclusions: We conclude that db-cAMP attenuates the lung injury by cold 
preservation and ischemia-reperfusion, at least partly by protection of the 
vascular endothelium. (J Thorac Cardiovasc Surg 1997;114:635-42) 
k ung transplantation is an established therapeutic procedure for terminal respiratory failure. How- 
ever, the duration of clinical lung preservation is
limited to 10 hours, 1 which is shorter than that of 
other parenchymal organs. Prevention of the dam- 
age caused by cold preservation and ischemia-reper- 
fusion may help to solve the problem of the shortage 
of donors, which is one of the biggest issues in lung 
transplantation, and to improve the operative out- 
come. Therefore we have continued to develop a 
highly reliable preservative solution for the lung. 2-v 
In the meantime, our electron microscopic exami- 
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nations have revealed that injury of the vascular 
endothelium by cold preservation is one of the 
factors responsible for reperfusion-induced dam- 
age.2, 4-7 
Dibutyryl adenosine 3',5'cyclic monophosphate 
(dibutyryl cAMP, db-cAMP) is a membrane-perme- 
able adenosine 3',5'cyclic monophosphate (cAMP) 
analog that is deacylated after its entry into the cell, 
changing to cAMP. s' 9 The cAMP functions as an 
intracellular second messenger and has a protective 
effect on the vascular endothelium. Because of these 
features, db-cAMP has been reported to be effective 
in preventing lung injury induced by endotoxins, t° 
lipid hydroperoxides, 11 oxidant gases, 12 and air em- 
boli. 13 On the other hand, when attention has been 
focused on the damage caused by ischemia-reperfu- 
sion and organ preservation, the effectiveness of 
db-cAMP against injury of the heart TM and liver is 
caused by cold preservation has been reported. It 
was also found that db-cAMP is effective against he 
lung injury caused by warm ischemia-reperfu- 
sion.16, 17 Moreover, we have previously reported 
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Fig. 1. Schematic representation f the perfusion model: 
The left lung of the experimental lung and the deoxygen- 
ator lung were ventilated with 100% oxygen and a hypoxic 
gas mixture (inspired oxygen fraction = 0.04, inspired 
carbon dioxide fraction = 0.08, and inspired nitrogen 
fraction = 0.88). The circuit was filled with 40 ml of 
heparinized blood drawn from three other rats. The blood 
deoxygenated by the deoxygenator lung was perfused 
through the experimental lung, oxygenated again, and 
then recirculated to the deoxygenator lung, This model 
was set up in a chamber at 37 ° C and a humidity of 100%. 
the protective effect of the combination use of 
db-cAMP, nitroglycerin, and N-acetylcysteine in 
cold lung preservation. 5-7 However, no detailed re- 
ports have been published that specifically describe 
the effect of  db-cAMP itself against lung damage 
caused by cold preservation and ischemia-reperfu- 
sion. 
In this report, with an ex vivo isolated rat lung 
perfusion model, we assessed the hypothesis that the 
protective ffect of db-cAMP on the vascular endo- 
thelium might attenuate the lung injury caused by 
cold preservation and ischemia-reperfusion. 
Materials and methods 
Donor procedure. Rats were anesthetized by an intra- 
peritoneal injection of sodium pentobarbital (30 mg/kg) 
and intubated after tracheotomy. The animals were oper- 
ated on under the following ventilation conditions with 
the use of a volume-controlled respirator (model SN 
480-7; Shinano, Tokyo, Japan): room air, tidal volume = 
3.0 ml/body, respiration rate = 60 breaths/rain, o positive 
end-expiratory pressure (PEEP). After a median abdom- 
inal incision, heparin (400 units) was injected into the 
inferior vena cava. Then a median sternotomy was per- 
formed and a 14-gauge pulmonary arterial ¢annula was 
inserted into the right ventricular outflow tract. The 
abdominal aorta and vena cava, the right and left ventri- 
cles, and the !eft atrial appendage were incised to facilitate 
free flow of the pulmonary venous blood. PEEP at a 
pressure of 2 cm H20 was then applied to the airway. The 
pulmonary vascular bed was flushed with a perfusate 
(4 ° C, 50 ml) containing prostaglandin E1 (10/xg) from a 
height of 20 cm. After the heart-lung block had been 
harvested, the pressure of the airway was kept positive at 
14 cm H20,  the tracheal tube was clamped, and the right 
pulmonary hilus was ligated. The right upper and middle 
lobes were resected and frozen to measure cAMP levels in 
the lung tissue. Then the heart-lung block was immersed 
in the preservative solution at 4 ° C. 
Deoxygenator lung procedure. Anesthesia, ventilation, 
heparin injection, and insertion of a pulmonary arterial 
cannula were performed as in the donor lung procedure. 
The abdominal aorta and vena cava. the right and left 
ventricles, and the left atrial appendage were resected to 
facilitate free flow of the pulmonary venous blood. PEEP 
was applied at a pressure of 2 cm H20 , the tracheal tube 
was clamped at maximal inspiratory capacity, and the 
heart-lung block was harvested. Lungs of both sides were 
used as deoxygenators. 
Reperfusion. Reperfusion of the experimental rat lung 
was performed in an ex vivo rat lung perfusion model at 
37 ° C in a chamber at a humidity of 100% for 60 minutes. 
This model was originally established by Decampos and 
associates ~8 and was described previously. We have con- 
firmed its effectiveness and have presented an experiment 
using this model. 7 The circuit was filled with 40 ml of 
heparinized blood drawn from three other rats, which 
were put to death separately. The blood was kept at a 
temperature of 37 ° C. The right lower and mediastinal 
lobes of the experimental lung were resected immediately 
before reperfusion, and the lower lobe was used for 
measurement of cAMP level in the lung tissue and the 
mediastinal lobe for transmission electron microscopic 
examination. 
The left lung was ventilated under the following condi- 
tions: inspired oxygen fraction = 1.0, tidal volume = 1.5 
ml/body, respiration rate = 40 breaths/min, and PEEP = 
2 cm H20. The deoxygenator lung was maintained under 
the following ventilation conditions: mixed gas (inspired 
oxygen fraction - 0.04, inspired carbon dioxide fraction = 
0.08, inspired nitrogen fraction - 0.88), tidal volume = 
3.0 ml/body, respiration rate - 60 breaths/min, and 
PEEP = 2 cm H20. Tile blood deoxygenated by the 
deoxygenator lung was perfused through the experimental 
lung, oxygenated again, and then recirculated to the 
deoxygenator lung. The flow rate of perfusion was grad- 
ually increased to 4 ml/min in the initial 10 minutes and, 
with a roller pump (model No. 7553-80; Cole Parmer 
Instrument Co., Chicago, Ill.), it was kept at 4 ml/min 
thereafter until the end of the experiment (Fig. 1). The pH 
value of the perfused blood was adjusted with sodium 
bicarbonate, if necessary, so as to keep the pH of the 
blood returning from the deoxygenator lung between 7.35 
and 7.45. 
When severe pulmonary edema of the experimental 
lung occurred and water exuded from the tracheal tube, 
reperfusion was discontinued. 
Experimental groups, Male Louis rats weighing about 
300 gm were used in the experiments. They were divided 
into three groups (each n = 6) according to the presence 
or absence of additional db-cAMP in the preservative 
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Table I. Data on perfused blood and deoxygenator lung 
Fresh group Control group db-cAMP group 
Hemoglobin i  circulating blood (gm/dl) 
Before 11.5 + 1.2 10.9 ± 0.6 11.2 _+ 1.2 
Po2 of blood drained from deoxygenator lung (mm Hg) 
Before 39.3 ± 5.9 40.6 ± 4.2 37.0 ± 7.4 
10 min 40.0 ± 1.3 39.6 -+ 3.0 39.4 ± 4.2 
20 rain 40.6 ± 1.9 38.3 ± 2.3 41.4 ± 2.4 
30 min 40.9 + 2.1 38.7 ± 2.3 41.3 ± 3.4 
40 rain 40.3 ± 1.9 39.3 ± 1.7 41.9 ± 2.6 
50 rain 40.3 ± 2.3 39.4 ± 2.4 41.4 ± 2.7 
60 rain 40.0 + 2.3 38.3 -+ 3.2 41.5 +_ 1.8 
Pcoa of blood drained from deoxygenator lung (ram Hg) 
Before 40.8 ± 7.2 39.4 ± 3.9 42.0 ± 5.0 
10 rain 45.5 ± 3.4 43.3 -+ 3.7 45.7 2 4.4 
20 min 48.0 ± 1.9 45.9 +_ 2.9 44.8 ± 3.7 
30 min 45.2 ± 5.4 45.7 ± 3.6 46.4 ± 4.7 
40 rain 46.0 ± 2.2 45.4 _+ 5.1 45.8 -+ 4.8 
50 rain 45.1 ± 2.8 42.9 ± 4.8 47.1 ± 5.3 
60 rain 44.8 ± 2.2 44.3 ± 2.7 44.9 ± 4.8 
The hemoglobin level of the priming blood in the circuit showed no difference among the three groups. There was no significant difference among the groups 
in the blood gas analysis data of the pulmonary venous blood rained from the deoxygenator lung before and throughout reperfusion. Pos, Oxygen tension; 
Pco2, carbon dioxide tension. 
solution and cold ischemia (4 ° C, 15 hours). The rats in 
the fresh group received pulmonary flushing only with the 
solution, followed directly by reperfusion of the left lung 
for 60 minutes. The lungs were flushed with the solution 
alone or with the solution plus db-cAMP (2 mmol/L) in 
the control and the db-cAMP groups, respectively. In 
these two groups, the lungs were immersed in the solution 
used for flushing for 15 hours at 4 ° C, followed by 
reperfusion. 
Preservative solution and drugs. The solution used in 
these experiments was an organ preservative solution with 
the ionic composition of extracellular fluid and nonreduc- 
ing disaccharide trehalose, which has a cell membrane- 
protecting effect. 19'2° The solution had the following 
composition: Na + 100 mmol/L, K ++ 44 mmol/L, glu- 
conate 100 mmol/L, phosphate 25 mmol/L, trehalose 
4.1%, hydroxyethyl starch 3%, osmolariiy 366 mOsm/L, 
and pH 7.40. 
The db-cAMP was kindly provided by Dai-Ichi Phar- 
maceutical Co., Ltd., Tokyo, Japan, and prostaglandin E~ 
by Ono Pharmaceutical Industrial Co., Ltd., Osaka, Ja- 
pan. 
Physiologic evaluation. The pulmonary venous blood 
of the experimental lung or deoxygenator lung coming 
from the incised left atrium and ventricle were collected 
for blood gas analysis. Analyses were performed immedi- 
ately before and every 10 minutes after the start of 
reperfusion until the end of reperfusion, with an auto- 
matic blood gas analyzer (ABL300; Radiometer A/S, 
Copenhagen, Denmark). The data were used to calculate 
the pulmonary shunt ratio (Qs/Qt), with the following 
formula: Qs/Qt (%) = (Cc - Ca)/(Cc - Cv) × 100, where 
Cc, Ca, and Cv represent the oxygen content in the blood 
of the pulmonary capillary, pulmonary artery, and pulmo- 
nary vein, respectively. The peak airway pressure and 
mean pulmonary arterial pressure were monitored contin- 
uously and recorded at 10-minutes intervals with a pres- 
sure-monitoring system (AP-641G; Nihon Kohden, To- 
leyo, Japan). The lower one third of the left lung was 
resected at the end of reperfusion and the wet tissue was 
weighed. Then it was dried at 55 ° C for 72 hours, the dry 
tissue was weighed, and the wet/dry weight ratio of the 
lung tissue (W/D ratio) was calculated. For assessment of 
the stability of the experimental system, the W/D ratio of 
the left lung tissue of the deoxygenator was similarly 
calculated. 
Lung tissue cAMP level. As stated earlier, the right 
upper and middle lobes were resected directly after 
flushing and the right lower lobe directly before reperfu- 
sion, and the cAMP level in the lung tissues was mea- 
sured. The tissues were frozen quickly with liquid nitrogen 
after removal and stored at -80°C Until measurement. 
The samples were homogenized with ice-cooled 6% tri- 
chloroacetic acid (2 ml). After centrifugation, trichloro- 
acetic acid was removed with ether from the supernatant. 
Then the samples were measured by immunoassay with a 
radioimmunoassay kit (cAMP Kit; Yamasa, Chiba, Ja- 
pan). The protein content was quantified by the method of 
Lowry and coworkers. 2~ 
Light microscopic examination. The tissue samples 
that were freeze-preserved with liquid nitrogen at the end 
of reperfusion were stained for histologic examination by 
hematoxylin and eosin. Also, an immunohistochemical 
study was conducted with anti-rat granUlocyte antibody 
(BMA T-3105); ten visual fields were randomly selected at 
×200 magnification from each sample, and the total 
granulocyte count in the visual fieldS was compared 
among the groups. 
Transmission electron microscopic examination. The 
right mediastinal lobe was harvested directly before reper- 
fusion and the tissue was fixed in 2.5% glutaraldehyde. 
Endothelial cells of the fine (about 100 nm in diameter) 
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Fig. 2. Pulmonary shunt ratio: The pulmonary shunt ra- 
tio in the db-cAMP group was as low as that in the fresh 
group. The shunt ratio in the control group was signifi- 
cantly higher than in the db-cAMP group or the fresh 
group throughout the experiment, being 46.8% _+ 30.8% 
at the end of reperfusion. *p < 0.01, fresh and db-cAMP 
versus control. 
pulmonary arteries were examined by transmission elec- 
tron microscopy (original magnification ×5000). 
Statistical analysis. All the numeric values in the text, 
figures, and table are expressed as the mean -+ standard 
deviation. Statistical significance was evaluated by analysis 
of variance, Scheffe's multiple comparison test, and paired 
t test. Ap value < 0.05 was considered significant. These 
analyses were performed with the use of StatView J-4.02 
(Abacus Concepts Inc., Berkeley, Calif). 
Animal treatment. All animals received humane care in 
compliance with the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labora- 
tory Animal Resources and published by the National Insti- 
tutes of Health (NIH Publication No. 86-23, revised 1985). 
Results 
The data on perfused blood and deoxygenator 
lung. The hemoglobin level of the priming blood of 
the circuit showed no difference among the three 
groups. No significant difference was apparent 
among the three groups in the blood gas analysis 
data of the pulmonary venous blood drained from 
the deoxygenator lung before and throughout the 
reperfusion (Table I). The W/D ratio of the deoxy- 
genator lung at the end of reperfusion was 5.17 _+ 
0.16 in the fresh group, 5.03 .+ 0.25 in the control 
group, and 5.22 ± 0.32 in the db-cAMP group, 
which showed no evidence of injury. Thus the 
stability of the experimental system was confirmed. 
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Fig. 3. Peak airway pressure (Paw): Throughout the exper- 
iment, peak airway pressure in the db-cAMP group and in 
the fresh group was significantly ower than in the control 
group. (***p < 0.01, fresh and db-cAMP vs control; **p < 
0.01, fresh vs control, p = 0.02, db-cAMP vs control; *p = 
0.01, fresh vs control, p = 0.02, db-cAMP vs control). 
Number of completed experiments. In the flesh 
group and the db-cAMP group, reperfusion was 
successfully achieved for 60 minutes in all experi- 
ments. However, in the control group, reperfusion 
was possible for 60 minutes in five experiments, but 
it was discontinued 20 minutes after the initiation of 
reperfusion in one experiment because of severe 
pulmonary edema. 
Pulmonary shunt ratio. The pulmonary shunt 
ratios were very low in the db-cAMP group: 4.0% -+ 
1.6%, 3.4% _+ 1.1%, 3.2% _+ 1.3%, 3.1% + 1.1%, 
3.1% -+ 1.4%, and 3.4% _+ 1.2% at 10, 20, 30, 40, 50, 
and 60 minutes after the start of reperfusion, respec- 
tively. These values were similar to those in the fresh 
group (5.7% _+ 1.7%, 5.1% _+ 0.6%, 4.2% _+ 1.1%, 
4.7% _+ 1.1%, 4.3% _+ 1.9%, and 4.5% +_ 1.2%, 
respectively). On the other hand, the shunt ratios in 
the control group were 27.8% ,+ 13.8%, 46.8% ,+ 
32.6%, 36.7% ± 21.1%, 39.2% _+ 22.3%, 46.3% ± 
30.8%, and 46.8% +_ 30.8%, respectively. Thus the 
pulmonary shunt ratios in the db-cAMP and in the 
fresh group were significantly lower than those in 
the control group throughout the experiment (p < 
0.01) (Fig. 2). 
Peak airway pressure. Throughout he experi- 
ment, peak airway pressures in the db-cAMP group 
were low: 10.5 .+ 0.7, 10.8 .+ 0.7, 11.3 .+ 0.6, 11.4 _+ 
0.7, 11.7 _+ 0.5, and 11.8 .+ 0.6 mm Hg at 10, 20, 30, 
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Fig. 4. Mean pulmonary arterial pressure (Ppa): Mean pul- 
monary arterial pressure in the db-cAMP group 10 minutes 
after the initiation of reperfusion was significantly lower than 
in the control group. Thereafter, mean pulmonary arterial 
pressure tended to be lower in the db-cAMP group until the 
end of the experiment, but there was no significant difference 
among the three groups (*p = 0.04, db-cAMP vs control). 
40, 50, and 60 minutes after the start of reperfusion, 
respectively. These values were identical to those in 
the fresh group (9.3 + 1.4, 9.8 _+ 1.3, 10.2 _+ 1.2, 
10.5 _+ 1.1, 10.6 _+ 0.9, and 10.8 _+ 0.9 mm Hg, 
respectively). Peak airway pressures in the control 
group were 18.6 _+ 5.7, 21.2 +_ 8.5, 20.4 + 8.3, 21.5 _+ 
9.1, 22.1 _+ 10.0, and 21.8 _+ 9.4 mm Hg, respectively. 
Thus, throughout the experiment, peak airway pres- 
sures in the db-cAMP and in the fresh groups were 
significantly lower than those in the control group 
(after 10 and 20 minutes: p < 0.01, fresh and 
db-cAMP vs control; after 30 and 40 minutes: p < 
0.01, fresh vs control, p = 0.02, db-cAMP vs control; 
after 50 and 60 minutes: p = 0.01, fresh vs control, 
p = 0.02, db-cAMP vs control) (Fig. 3). 
Mean pulmonary arterial pressure. Mean pul- 
monary arterial pressure 10 minutes after the start 
of reperfusion was 14.0 _+ 2.2 mm Hg in the control 
group and 10.8 _+ 1.7 mm Hg in the db-cAMP group, 
and the difference between the two groups was 
significant (p = 0.04). Thereafter, mean pulmonary 
arterial pressure showed a tendency to increase in 
the control group until the end of the experiment, 
but no significant difference was detected among the 
three groups (Fig. 4). 
W/D ratio. W/D ratio at the end of reperfusion 
was 5.45 _+ 0.23 in the fresh group, 14.20 +_ 3.43 in 
15- 
fresh control db-cAMP 
Fig. 5. W/D ratio: The W/D ratio at the end of reperfu- 
sion was 5.45 -+ 0.23 in the fresh group, 14.20 -+ 3.43 in the 
control group, and 5.99 _+ 1.50 in the db-cAMP group; it 
was significantly (*p < 0.01) lower in the db-cAMP and 
fresh groups than in the control group. 
the control group, and 5.99 + 1.50 in the db-cAMP 
group, significantly lower in the db-cAMP and fresh 
groups than in the control group (p < 0.01) (Fig. 5). 
Lung tissue cAMP level. The cAMP level in the 
lung tissue was 15.0 + 6.8 pmol/mg protein imme- 
diately after flushing and 12.3 _+ 4.4 pmol/mg pro- 
tein before reperfusion i  the control group; thus no 
significant difference was detected before and after 
preservation. 
Light microscopic examination. Histologic study 
with hematoxylin and eosin stain revealed almost 
normal findings of the lung tissue after reperfusion 
in the db-cAMP group and in the fresh groups. On 
the contrary, in the control group, marked edema 
was present around the blood vessels in the lung 
tissue after reperfusion. 
In the immunohistochemical study with anti-rat 
granulocyte antibody, the total granulocyte count in 
ten visual fields was zero to two cells in each group, 
indicating almost no infiltration of granulocytes 
during reperfusion. 
Transmission electron microscopic examination. 
Examination by transmission electron microscopy of 
the fine pulmonary arterial endothelium after pres- 
ervation revealed almost normal endothelium in the 
fresh group (Fig. 6, A). In the control group, how- 
ever, detachment of the endothelial cells from the 
basal lamina were observed, indicating apparent 
damage of the pulmonary vascular endothelium 
(Fig. 6, B). On the other hand, in the db-cAMP 
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Fig. 6. Transmission electron microscopic examination (original magnification ×5000): The pulmonary 
arterial endothelium after preservation looked almost normal in the fresh group (A). In the control group 
(B), there was detachment of endothelial cells from the basal amina (arrowheads), indicating damage of 
vascular endothelium. In the db-cAMP group (C), the endothelial cells were satisfactorily preserved, 
showing the protective ffect of db-cAMP. 
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group, the endothelial cells were as satisfactorily 
preserved as in the fresh group, showing the protec- 
tive effect of db-cAMP (Fig. 6, C). 
Discussion 
In the present experiment, we investigated the 
effectiveness of db-cAMP, which elevates the intra- 
cellular cAMP level, against he lung injury induced 
by cold preservation and ischemia-reperfusion. A 
cell membrane-permeable cAMP analog, db-cAMP 
is deacylated after its entry into the cells and 
changes to cAMP. 8' 9 Furthermore, db-cAMP and 
its metabolite N6-monobutyryl cAMP have an inhib- 
itory effect on cAMP phosphodiesterase, thereby 
elevating the intracellular cAMP level. 22 
It has been reported that cAMP has a protective 
effect on the vascular endothelium as an intracellu- 
lar second messenger, and therefore its analog db- 
cAMP is effective against endotoxins, 1° lipid hy- 
droperoxides, tl oxidant gases, 12 air emboli, 13 cold 
preservation of the heart 14 and liver, 15 and lung 
damage resulting from warm ischemia-reperfu- 
sion.16, 17 In addition, the combination use of db- 
cAMP, nitroglycerin, and N-acetylcysteine has been 
proved effective in cold lung preservationJ -7 How- 
ever, no detailed investigations have so far been 
conducted on the effect of db-cAMP itself against 
the lung damage resulting from cold preservation 
and ischemia-reperfusion. 
In our current study, lungs flushed with the solu- 
tion containing db-cAMP showed excellent function 
equivalent to that of fresh lungs during reperfusion 
after cold preservation for 15 hours. 
Electron microscopy showed less damage of the 
pulmonary arterial endothelium in the db-cAMP 
group than in the control group in specimens har- 
vested before reperfusion, indicating the protective 
effect of db-cAMP on the vascular endothelium. 
Moreover, on macroscopic examination of the color 
and homogeneity of perfusion and ventilation, the 
lungs of the db-cAMP group showed more satisfac- 
tory pulmonary function even at an extremely early 
stage (within 5 minutes after the start of reperfu- 
sion) than did the control lungs. These results 
suggest that the protective effect of db-cAMP 
against lung injury caused by cold preservation and 
ischemia-reperfusion can be attributed, at least in 
part, to suppression of vascular endothelial damage 
during lung preservation. 
The protective ffect of cAMP on the vascular 
endothelium is said to result from its three actions: 
suppression of vascular permeability, 1°-13, 16, 17, 23, 24 
relaxation of vascular smooth muscle, 11' 17 and sup- 
pression of adhesion of neutrophils to the vascular 
wall.14. 25 In our immunohistochemical experiment, 
however, granulocyte adhesion to the vascular wall 
and infiltration into the tissue were almost absent in 
all the groups. Consequently, it appears less likely 
that suppression of granulocyte adhesion to the 
vascular wall by db-cAMP contributed to its protec- 
tive effect. On the other hand, the direct measure- 
ment of vascular permeability and degree of con- 
traction of the smooth muscle cells was impossible 
in our experimental model. It is therefore necessary 
to conduct further investigations on the mechanism 
of the protective ffect of db-cAMP on the vascular 
endothelium. 
Ischemia of vascular endothelial 23 and smooth 
muscle cells 14 lowers the intracellular cAMP level by 
decreasing adenylate cyclase activity 23 and increas- 
ing phosphodiesterase activity. 14 In the current ex- 
periment, he content of cAMP in lung tissue tended 
to decrease in the control group during cold preser- 
vation, but the change was not significant (in the 
db-cAMP group, the cAMP level in the lung tissue 
could not be measured because of cross reaction 
problems on immunoassay). Because lung tissue is 
composed of various cells, we cannot deny that the 
level of cAMP in the tissue does not reflect the 
amount of cAMP in the vascular endothelial cells 
and smooth muscle cells. However, it may also be 
assumed that the cold ischemic state decreases 
tissue metabolism and, accordingly, the cAMP level 
does not change significantly. 
It is widely accepted that db-cAMP elevates the 
intracellular level of cAMP. We assume that in the 
current experimental model db-cAMP also raised 
the cAMP level in the vascular endothelial cells and 
smooth muscle cells of the lung, thereby producing a
protective ffect. 
In conclusion, db-cAMP, which elevates the intra- 
cellular level of cAMP as a second messenger, atten- 
uates the lung injury caused by cold preservation and 
ischemia-reperfusion. The scanning electron micro- 
scopic findings indicated that such a protective ffect 
may be due partly to the protective ffect of db-cAMP 
on the vascular endothelium. Further studies are re- 
quired to elucidate the details of the mechanism of this 
protective ffect of db-cAMP. 
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